Skip to content

PFL protocol

C24H30Cl2FN11O9Pt — CID 135659054

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;azanide;dichloroplatinum(2+);5-fluoro-1H-pyrimidine-2,4-dione
SMILESCl[Pt+2]Cl.Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2.O=c1[nH]cc(F)c(=O)[nH]1.[NH2-].[NH2-]
InChIInChI=1S/C20H23N7O7.C4H3FN2O2.2ClH.2H2N.Pt/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;5-2-1-6-4(9)7-3(2)8;;;;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);1H,(H2,6,7,8,9);2*1H;2*1H2;/q;;;;2*-1;+4/p-2/t12?,13-;;;;;;/m0....../s1
InChIKeyCFFKNNVOYKYCFO-ZIGBGYJWSA-L
MW901.55 g/mol
LogP1.28
Rot. Bonds10

About PFL protocol

PFL protocol (PubChem CID 135659054) has the molecular formula C24H30Cl2FN11O9Pt and a molecular weight of 901.55 g/mol. Its IUPAC name is (2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;azanide;dichloroplatinum(2+);5-fluoro-1H-pyrimidine-2,4-dione.

Molecular Properties

Compound NamePFL protocol
PubChem CID135659054
Molecular FormulaC24H30Cl2FN11O9Pt
Molecular Weight901.55 g/mol
Exact Mass900.12
IUPAC Name(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;azanide;dichloroplatinum(2+);5-fluoro-1H-pyrimidine-2,4-dione
SMILESCl[Pt+2]Cl.Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2.O=c1[nH]cc(F)c(=O)[nH]1.[NH2-].[NH2-]
InChIInChI=1S/C20H23N7O7.C4H3FN2O2.2ClH.2H2N.Pt/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;5-2-1-6-4(9)7-3(2)8;;;;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);1H,(H2,6,7,8,9);2*1H;2*1H2;/q;;;;2*-1;+4/p-2/t12?,13-;;;;;;/m0....../s1
InChIKeyCFFKNNVOYKYCFO-ZIGBGYJWSA-L
XLogP1.28
TPSA352.56 Ų
H-Bond Donors9
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms48
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500901.55
LogP ≤ 51.28
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze PFL protocol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of PFL protocol?
The IUPAC name of PFL protocol (CID 135659054) is (2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;azanide;dichloroplatinum(2+);5-fluoro-1H-pyrimidine-2,4-dione.
What is the SMILES notation for PFL protocol?
The canonical SMILES for PFL protocol is Cl[Pt+2]Cl.Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2.O=c1[nH]cc(F)c(=O)[nH]1.[NH2-].[NH2-].
What is the InChIKey of PFL protocol?
The InChIKey is CFFKNNVOYKYCFO-ZIGBGYJWSA-L. The full InChI is InChI=1S/C20H23N7O7.C4H3FN2O2.2ClH.2H2N.Pt/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;5-2-1-6-4(9)7-3(2)8;;;;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);1H,(H2,6,7,8,9);2*1H;2*1H2;/q;;;;2*-1;+4/p-2/t12?,13-;;;;;;/m0....../s1.
What are the key properties of PFL protocol?
PFL protocol has a molecular weight of 901.55 g/mol, XLogP of 1.28, 10 rotatable bonds, 9 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for PFL protocol is sourced from PubChem (CID 135659054), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.